Professor Julie Stout

Professor Julie Stout, a leading neuroscientist at Monash University’s Turner Institute, discusses a groundbreaking gene therapy trial for Huntington’s disease. She explains how this innovative approach dramatically slows progression by reducing harmful protein levels in the brain. Julie shares insights on the personal and social devastations of the disease, the trial's encouraging 75% slowing of symptoms, and the path to potential therapy access in Australia. Her enthusiasm highlights both the promise and the challenges ahead in treating this cruel condition.